Clinical Trials Browser

Phase 1 × tumor necrosis factor-alpha, CNGRC fusion protein, human × Clear all

NCT00419328 2022-07-21

A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT00305084 2019-10-04

Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors

Phase 1 Completed

15 enrolled 20 charts

Neoplasms

NCT00878111 2018-08-29

Study of NGR-hTNF Administered at High Doses in Patient With Advanced or Metastatic Solid Tumour

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00483093 2014-05-30

Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00098943 2012-09-24

NGR-TNF in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

CNSEndocrineGastrointestinalGenitourinaryHead & Neck

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Carcinoma, Renal Cell, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Parathyroid Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Thyroid Carcinoma, Anaplastic